Safety of Canagliflozin in Patients with Type 2 Diabetes

E-ISSN： 2212-3911|9|2|127-132

ISSN： 1574-8863

Source： Current Drug Safety, Vol.9, Iss.2, 2014-07, pp. : 127-132

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long‐term efficacy and safety of canagliflozin over 104 weeks in patients aged 55–80 years with type 2 diabetes

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 3, 2015-03 ,pp. : 294-303

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of canagliflozin on serum uric acid in patients with type 2 diabetes mellitus

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 4, 2015-04 ,pp. : 426-429

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, placebo‐controlled, parallel‐group comparative study

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 2, 2018-02 ,pp. : 453-457

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management of patients with type 2 diabetes

By Nelson Scott E.

Current Medical Research and Opinion, Vol. 27, Iss. 10, 2011-10 ,pp. : 1931-1947

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of glimepiride as initial treatment in Chinese patients with Type 2 diabetes mellitus

By Guo Xiao-hui Lv Xiao-feng Han Ping Zhang Xiu-zhen Yang Hua-zhang Duan Wen-ruo Gao Yan

Current Medical Research and Opinion, Vol. 29, Iss. 3, 2013-03 ,pp. : 169-174

Informa Healthcare

Access to resources Recommend Favorite